Patent application number | Description | Published |
20110077564 | PNEUMATIC COMPRESSION GARMENT WITH NOISE ATTENUATING MEANS - A pneumatic compression garment comprises a flexible member for placement on a limb of a human body. A bladder in the flexible member defines an inflatable chamber. The bladder has an opening through which the inflatable chamber is inflated. A port mounted on the bladder has an air inlet adapted for communication with a source of pressurized air and an air outlet in communication with the inflatable chamber via the opening in the bladder. Pressurized air is delivered from into the inflatable chamber for inflating the inflatable chamber and thereby applying a compression force to the limb when the flexible member is in place on the limb. Noise attenuating means associated with the bladder opening is provided for reducing noise from air flow through the opening into the inflatable chamber. | 03-31-2011 |
20110077566 | PNEUMATIC COMPRESSION GARMENT WITH NOISE ATTENUATING MEANS - A compression garment for applying compression to a part of a wearer's body includes a flexible member, an inflatable bladder defining an inflatable chamber, a port for communication between a source of pressurized air and the inflatable chamber, and noise attenuating means. The noise attenuating means can include noise attenuating members on an air impingement surface of the inflatable bladder, or at least one air flow aperture in a delivery tube that delivers air into the inflatable chamber. | 03-31-2011 |
20110196284 | SYSTEMS AND METHODS FOR DETECTION OF WOUND FLUID BLOOD AND APPLICATION OF PHOTOTHERAPY IN CONJUNCTION WITH REDUCED PRESSURE WOUND TREATMENT SYSTEM - Wound fluid blood detection systems and methods are described that are operable in conjunction with reduced pressure wound treatment (RPWT) systems, as well as ancillary therapy and monitoring systems applied concurrently with RPWT systems. The blood detection monitor operates by optically characterizing the content of wound fluids to the extent of identifying percentage blood content. This identification relies upon the transmission of select wavelengths of light across a volume of wound fluid to a photo detector (connected to signal processing instrumentation) capable of quantifying the absorption characteristics of the fluid. The detection components may be implemented in conjunction with either a fluid flow conduit (i.e. the reduced pressure tubing directing fluid away from the wound dressing) or more directly in association with the materials that comprise the wound dressing positioned within the wound bed itself. In addition, the present invention is configured to operate in conjunction with blood gas monitoring, systems operating with the RPWT. Finally, the components of the systems that serve to illuminate the wound bed, lend themselves to use in conjunction with illumination in discreet electromagnetic wave wavelengths suitable for the application of phototherapy. | 08-11-2011 |
20140094726 | VASCULAR COMPRESSION SYSTEM - A vascular compression system includes a compression garment and a controller for compressing a body part of a person. In some embodiments, the compression garment is a foot cuff or a leg sleeve. The controller inflates compression garment apparatus includes a compression garment and a pressurizer. The pressurizer has instructions for executing cyclic compression cycles for applying intermittent compression therapy to the body part. Each compression cycle includes an inflation phase and a vent phase. At least one of the inflation phases includes a pre-fill step and a therapeutic step. In the pre-fill step, gas pressure in the inflatable chamber may be increased at a reduced rate, and in the therapeutic step, the gas pressure in the inflatable chamber may be increased at a rapid rate. | 04-03-2014 |
20140142481 | PNEUMATIC COMPRESSION GARMENT WITH NOISE ATTENUATING MEANS - A pneumatic compression garment comprises a flexible member for placement on a limb of a human body. A bladder in the flexible member defines an inflatable chamber. The bladder has an opening through which the inflatable chamber is inflated. A port mounted on the bladder has an air inlet adapted for communication with a source of pressurized air and an air outlet in communication with the inflatable chamber via the opening in the bladder. Pressurized air is delivered from into the inflatable chamber for inflating the inflatable chamber and thereby applying a compression force to the limb when the flexible member is in place on the limb. Noise attenuating means associated with the bladder opening is provided for reducing noise from air flow through the opening into the inflatable chamber. | 05-22-2014 |
Patent application number | Description | Published |
20140120438 | SYSTEMS AND METHODS FOR ENHANCING FUEL CELL VEHICLE STARTUP - Methods and systems for enhancing the performance of fuel cells in fuel cell vehicles. Some embodiments comprise a current control module for controlling the application of a load to the fuel cell and a voltage monitoring module for monitoring one or more voltages within the fuel cell. The current control module may be configured to apply a delay period before applying a load to the fuel cell after the fuel cell has reached an open circuit voltage. In other embodiments, a fixed delay period may be applied before applying a load to the fuel cell after the fuel cell has reached an open circuit voltage or, for example, an incremental set of delay periods that increase as measured temperature decreases. | 05-01-2014 |
20140205924 | SELECTIVELY REACTING TO THE MINIMUM CELL VOLTAGE DROP RATE IN A FUEL CELL SYSTEM - A system and method that monitor the rate of a voltage drop of fuel cells in a fuel cell stack to determine whether the voltage drop is a result of cathode reactant starvation or anode reactant starvation. The method looks at a falling voltage of a fuel cell to determine whether the rate of the fall in voltage indicates that hydrogen starvation of the anode of the fuel cell is occurring. The method also looks at the actual voltage of the fuel cell that is falling to determine whether it is a below a predetermined minimum voltage threshold also indicating that hydrogen starvation of the anode of the fuel cell is occurring. If hydrogen starvation is occurring, the method performs power limiting of the fuel cell stack either based on the rate or the voltage level. | 07-24-2014 |
20140272652 | SYSTEMS AND METHODS FOR PREDICTING POLARIZATION CURVES IN A FUEL CELL SYSTEM - The present disclosure relates to systems and methods that may be used to predict a performance metric of a fuel cell. A system consistent with the present disclosure may include sensors in communication with the fuel cell stack, a performance metric prediction system, and a control system. The performance metric prediction system may determine a current density based on inputs provided by the sensors at a plurality of time periods, calculate a first parameter while the current density is below a lower threshold, and calculate a second parameter while the current density is above an upper threshold. The first parameter and the second parameter may be used to selectively adjust a fuel cell polarization curve over time. Based upon the polarization curve, a performance metric of the fuel cell stack may be predicted. The control system may implement a control action based upon the performance metric. | 09-18-2014 |
Patent application number | Description | Published |
20120162254 | OBJECT MAPPING TECHNIQUES FOR MOBILE AUGMENTED REALITY APPLICATIONS - Techniques are disclosed that involve mobile augmented reality (MAR) applications in which users (e.g., players) may experience augmented reality (e.g., altered video or audio based on a real environment). Such augmented reality may include various alterations. For example, particular objects may be altered to appear differently. Such alterations may be based on stored profiles and/or user selections. Further features may also be employed. For example, in embodiments, characters and/or other objects may be sent (or caused to appear) to other users in other locations. Also, a user may leave a character at another location and receive an alert when another user/player encounters this character. Also, characteristics of output audio may be affected based on events of the MAR application. | 06-28-2012 |
20120162255 | TECHNIQUES FOR MOBILE AUGMENTED REALITY APPLICATIONS - Techniques are disclosed that involve mobile augmented reality (MAR) applications in which users (e.g., players) may experience augmented reality. Further, the actual geographical position of MAR application objects (e.g., players, characters, and other objects) may be tracked, represented, and manipulated. Accordingly, MAR objects may be tracked across multiple locations (e.g., multiple geographies and player environments). Moreover, MAR content may be manipulated and provided to the user based on a current context of the user. | 06-28-2012 |
20120166993 | PROJECTION INTERFACE TECHNIQUES - Techniques are disclosed that involve projection interfaces, such as multitouch projected displays (MTPDs). For example, a user may activate a projection interface without having to interact with the a non-projected interface (e.g., a keyboard or keypad). Also, a user may select or adjust various device settings. Moreover, various user applications may be allocated among a projected interface and another display (e.g., an integrated display device). Such techniques may be employed in various environments, such as ones in which a display input devices exist in addition to a projection interface. Through such techniques, ease of use for projection interfaces may be advantageously achieved. | 06-28-2012 |
20150279109 | OBJECT MAPPING TECHNIQUES FOR MOBILE AUGMENTED REALITY APPLICATIONS - Techniques are disclosed that involve mobile augmented reality (MAR) applications in which users (e.g., players) may experience augmented reality (e.g., altered video or audio based on a real environment). Such augmented reality may include various alterations. For example, particular objects may be altered to appear differently. Such alterations may be based on stored profiles and/or user selections. Further features may also be employed. For example, in embodiments, characters and/or other objects may be sent (or caused to appear) to other users in other locations. Also, a user may leave a character at another location and receive an alert when another user/player encounters this character. Also, characteristics of output audio may be affected based on events of the MAR application. | 10-01-2015 |
Patent application number | Description | Published |
20090123388 | Prodrugs of Short-Chain Fatty Acids and Treatment Methods - Prodrugs made up of biologically-active short-chain fatty acids or derivatives thereof conjugated to neutral or cationic amino acids capable of intracellular transport by ATB | 05-14-2009 |
20100137236 | Compositions Comprising a GPR109 Ligand For Treating Disorders of the Digestive Tract and/or Cancer - Pharmaceutical compositions containing an effective amount of a ligand for GPR109 to decrease intracellular cAMP levels of a subject in combination with an effective amount of a DNA methyl transferase inhibito to reduce or inhibit downregulation of GPR109 in the intestinal epithelial cells of the subject relative to a control are provided. It has been discovered that ligands for GPR109 can be used to treat one or more symptoms of cancer, inflammatory disorders, and diarrhea. Representative CPR 109 ligands include, but are not limited to butyrate, β-hydroxybutyrate, nicotinic acid, acifran, and octanoate. Suitable DNA methyl transferase inhibitors include 5-azacytidine, 5-aza-2′-deoxytidine, 1-β-D-arabinfαmosyl-5-azacytosine and dihydro-5-azacytidine. Typically, the compositions are formulated to achieve a GPR 109 ligand serum blood level of about 1 to about 1000 μM. The compositions are useful for the treatment of one or more symptoms of cancer. Preferred cancers that can be treated using the disclosed compositions include, but are not limited to colon cancer, breast cancer and leukemia. Methods for treating cancer, inflammatory disorders, and diarrhea are also provided. | 06-03-2010 |
20100305184 | INHIBITORS OF THE ATB(0,+) TRANSPORTER AND USES THEREOF - The present invention includes inhibitors of the amino acid transporter ATB | 12-02-2010 |
20110245339 | PRODRUGS OF SHORT-CHAIN FATTY ACIDS AND TREATMENT METHODS - Prodrugs made up of biologically-active short-chain fatty acids or derivatives thereof conjugated to neutral or cationic amino acids capable of intracellular transport by ATB | 10-06-2011 |
20130142815 | ALPHA-METHYL-TRYPTOPHAN AS AN INHIBITOR OF INDOLEAMINE DIOXYGENASE - The present invention demonstrates for the first time that alpha-methyl-tryptophan is an inhibitor of the enzyme indoleamine diooxygenase (IDO). The present invention includes the use of alpha-methyl-tryptophan in methods of modulating immune responses and treating cancer and infections. | 06-06-2013 |
20130230512 | INHIBITORS OF THE ATB(0,+) TRANSPORTER AND USES THEREOF - The present invention includes inhibitors of the amino acid transporter ATB | 09-05-2013 |
20140024663 | ATB(0,+) AMINO ACID TRANSPORTER AS A DRUG TARGET FOR TREATMENT OF ESTROGEN RECEPTOR-POSITIVE BREAST CANCER - The present invention includes inhibitors of the amino acid transporter ATB | 01-23-2014 |
20140171504 | Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters - Methods of using one or more fumaric acid esters or pharmacologically active salts, derivatives, analogues, or prodrugs thereof to increase expression of fetal hemoglobin (HbF) are disclosed. The methods typically include administering to a subject an effective amount of one or more fumaric acid esters optionally in combination or alternation with hydroxyurea to induce HbF expression in the subject in an effective amount to reduce one or more symptoms of a sickle cell disorder, a hemoglobinopathy, or a beta-thalassemia, or to compensate for a genetic mutation is the human beta-globin gene (HBB) or an expression control sequence thereof. Pharmaceutical dosage units and dosage regimes for use in the disclosed methods are also provided. | 06-19-2014 |
Patent application number | Description | Published |
20090119637 | METHOD AND SYSTEM FOR SELECTING A SOFTWARE ARCHITECTURE FOR IMPLEMENTING SERVICE INTEGRATION - A method and system for selecting a technology to implement a service integration. Functional and non-functional service requirements are received. Technology preference relative weights for a pre-defined set of technologies and requirement relative weights for the requirements are received. Responses are received. The responses are associated with the requirements and with the requirement relative weights in a one-to-one correspondence. The responses are associated with the technology relative weights in a many-to-one correspondence. Each response indicates a characteristic that satisfies a requirement. A technology for implementing the service integration is selected from the pre-defined set of technologies based on the technology preference relative weights and the requirement relative weights. | 05-07-2009 |
20130007696 | PRESCRIBING A SOFTWARE ARCHITECTURE FOR IMPLEMENTING SERVICE INTEGRATION - An approach is provided for prescribing a first software architecture to implement service integration. To determine first products, a first weight of a first software architecture is multiplied by weights of first requirements of a service. To determine second products, a second weight of a second software architecture is multiplied by weights of second requirements of the service. The first and second requirements are satisfied, respectively, by first and second sets of responses respectively associated with the first and second software architectures. The first products are summed and the second products are summed to determine first and second summations, respectively. The first summation is determined to be greater than the second summation. Based on the first summation being greater than the second summation, the first software architecture instead of the second software architecture is selected and prescribed to realize the service in a service integration implementation. | 01-03-2013 |
20150046899 | PRESCRIBING A SOFTWARE ARCHITECTURE FOR IMPLEMENTING SERVICE INTEGRATION - An approach is provided for prescribing a software architecture to implement service integration. To determine first and second products, a first weight of a first software architecture is multiplied by weights of first requirements of a service and a second weight of a second software architecture is multiplied by weights of second requirements of the service. The first and second requirements are satisfied, respectively, by first and second sets of responses respectively associated with the first and second software architectures. A first summation of the first products is determined to be greater than a second summation of the second products. Based on the first summation being greater than the second summation, the first software architecture instead of the second software architecture is prescribed to realize the service in a service integration implementation. A work effort required to utilize the first software architecture to realize the service is estimated. | 02-12-2015 |